Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Lateral Sclerosis”

963 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 963 results

Not applicableStudy completedNCT03444428
What this trial is testing

The Relationship Between Arterial Stiffness and Respiratory Failure in Motor Neurone Disease

Who this might be right for
Motor Neurone DiseaseHypoxemia and/or Hypercapnia
Guy's and St Thomas' NHS Foundation Trust 13
Not applicableLooking for participantsNCT07224256
What this trial is testing

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

Who this might be right for
Tetraplegia/TetraparesisQuadriplegiaCervical Spinal Cord Injury+4 more
Neuralink Corp 6
Testing effectiveness (Phase 2)Study completedNCT04569435
What this trial is testing

Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Annexon, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00326625
What this trial is testing

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Teva Pharmaceutical Industries, Ltd. 366
Testing effectiveness (Phase 2)UnknownNCT02478450
What this trial is testing

Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Q Therapeutics, Inc. 30
Not applicableEnded earlyNCT02493491
What this trial is testing

Neurogenic Dysphonia/Dysphagia Registry

Who this might be right for
Neurogenic DysphoniaNeurogenic Dysphagia
Merz North America, Inc. 146
Testing effectiveness (Phase 2)Study completedNCT01089010
What this trial is testing

CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 67
Not applicableUnknownNCT01530438
What this trial is testing

Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Caen 90
Testing effectiveness (Phase 2)Study completedNCT03481348
What this trial is testing

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Ulm 20
Testing effectiveness (Phase 2)Study completedNCT04632225
What this trial is testing

Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Helixmith Co., Ltd. 18
Not applicableUnknownNCT04960540
What this trial is testing

Multimodal Brain Imaging Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 40
Not applicableUnknownNCT01650818
What this trial is testing

Aerobic Exercise Training in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Fondazione Salvatore Maugeri 40
Early research (Phase 1)Looking for participantsNCT07193953
What this trial is testing

Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALS
Sunnybrook Health Sciences Centre 6
Very early researchActive Not RecruitingNCT06889857
What this trial is testing

Safety and Efficacy of Intravenous Administration of SHED-CM for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Hitonowa Medical 10
Testing effectiveness (Phase 2)UnknownNCT04987671
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS

Who this might be right for
ALS
Amylyx Pharmaceuticals Inc. 14
Not applicableLooking for participantsNCT07334743
What this trial is testing

Identifying Biomarkers in ALS Patients Using Neuronal Derived Extracellular Vesicles

Who this might be right for
Amyotrophic Lateral SclerosisENGRAILED1
Fondation Ophtalmologique Adolphe de Rothschild 60
Not applicableLooking for participantsNCT06318598
What this trial is testing

Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano 200
Testing effectiveness (Phase 2)Study completedNCT02479802
What this trial is testing

Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Instituto Grifols, S.A. 13
Not applicableUnknownNCT03103815
What this trial is testing

Trial of Amivita in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Wujin People's Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT04505358
What this trial is testing

Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Samus Therapeutics, Inc.
Load More Results